Precision medicine depends on two fundamental capabilities: understanding disease at the genomic level and identifying treatments at the molecular level.  NVIDIA’s contributions to precision medicine extend far beyond accelerated computing, delivering a full-stack platform that translates hardware and software advancements directly into healthcare outcomes. Sequencing the human genome initially took more than a decade, and now it can be completed in a matter of hours. This dramatic shift goes beyond a technical milestone. It has enabled earlier detection, faster diagnoses, and more targeted therapies, fundamentally changing how diseases are understood and treated. This increase in sequencing speed has shifted the genomic bottleneck from data generation to data analysis. Faster sequencing is only valuable if downstream analysis can keep pace.…